Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis

2020 ◽  
Vol 72 (4) ◽  
pp. 576-587 ◽  
Author(s):  
François Santinon ◽  
Maxime Batignes ◽  
Majda Lyna Mebrek ◽  
Jerôme Biton ◽  
Gaëlle Clavel ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Receptor ◽  
Treg Cells ◽  
Receptor Type ◽  
Type Ii ◽  
Necrosis Factor

Correlation of CXCL10, Tumor Necrosis Factor Receptor Type II, and Galectin 9 With Disease Activity in Juvenile Dermatomyositis

2014 ◽  
Vol 66 (8) ◽  
pp. 2281-2289 ◽  
Author(s):  
F. Bellutti Enders ◽  
F. van Wijk ◽  
R. Scholman ◽  
M. Hofer ◽  
B. J. Prakken ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Disease Activity ◽  
Tumor Necrosis ◽  
Juvenile Dermatomyositis ◽  
Tumor Necrosis Factor Receptor ◽  
Receptor Type ◽  
Type Ii ◽  
Necrosis Factor

Soluble tumor necrosis factor receptor type II in the early diagnosis of fever in neutropenia

2002 ◽  
Vol 81 (7) ◽  
pp. 382-385 ◽  
Author(s):  
Goetz M. ◽  
Behre G. ◽  
Heussel G. ◽  
Steinmetz H. ◽  
Eigler A. ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Early Diagnosis ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Receptor ◽  
Receptor Type ◽  
Type Ii ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document